Search Results - "BEEH, K.M."

Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects by BEEH, K.M., BEIER, J., KORNMANN, O., BUHL, R.

“…Background: Matrix-metalloproteinases (MMPs) and their inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), are involved in the turnover of…”
Get full text

Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis by Beeh, K.M, Beier, J, Haas, I.C, Kornmann, O, Micke, P, Buhl, R

“…Idiopathic pulmonary fibrosis (IPF) is a disease of unknown aetiology. Increased oxidant burden and antioxidant, e.g. glutathione (GSH), deficiency in the…”
Get full text

Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease by Grönke, L, Beeh, K.M, Cameron, R, Kornmann, O, Beier, J, Shaw, M, Holz, O, Buhl, R, Magnussen, H, Jörres, R.A

“…Abstract This study aimed to evaluate the effect of a LTB4 receptor antagonist on inflammatory markers in induced sputum, in particular sputum neutrophilia, in…”
Get full text

Sputum induction leads to a decrease of exhaled nitric oxide unrelated to airflow by Beier, J, Beeh, K.M, Kornmann, O, Buhl, R

“…Measurement of exhaled nitric oxide (eNO) and analysis of induced sputum are both established noninvasive methods for studying airway inflammation in asthma…”
Get full text

PCR255 Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions by Requena, G., Rothnie, K., Noorduyn, S.G., Claussen, J., Schultze, M., Kossack, N., Richter, L., Vogelmeier, C., Beeh, K.M., Sharma, R., Compton, C., Ismaila, A.

Get full text

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma by Price, D B, Hernandez, D, Magyar, P, Fiterman, J, Beeh, K M, James, I G, Konstantopoulos, S, Rojas, R, van Noord, J A, Pons, M, Gilles, L, Leff, J A

“…Background: Inhaled corticosteroids (ICS) affect many inflammatory pathways in asthma but have little impact on cysteinyl leukotrienes. This may partly explain…”
Get full text

Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals by Beeh, KM, Ksoll, M, Buhl, R

“…Elevated serum immunoglobulin (Ig)E is the hallmark of atopy, and contributes to asthma and bronchial hyperresponsiveness in atopic individuals. In contrast,…”
Get full text

Effect of the oral leukotriene B 4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease by Grönke, L., Beeh, K.M., Cameron, R., Kornmann, O., Beier, J., Shaw, M., Holz, O., Buhl, R., Magnussen, H., Jörres, R.A.

“…This study aimed to evaluate the effect of a LTB 4 receptor antagonist on inflammatory markers in induced sputum, in particular sputum neutrophilia, in…”
Get full text

Classification of small cell lung cancer (SCLC): IASLC or VALG - beyond the limits of limited disease by Micke, P, Metz, T, Beeh, K.M, Hengstler, J, Buhl, R

Get full text

Stability of glutathione in induced sputum: impact of freezing by Beier, J, Beeh, K M, Kornmann, O, Buhl, R

“…Oxidative stress has repeatedly been linked to the pathogenesis of pulmonary disorders like asthma and chronic obstructive pulmonary disease. Measuring…”
Get more information

Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer by Beeh, K M, Beier, J, Ernst, M, Kornmann, O, Buhl, R

“…Neutrophilic inflammation is a major feature of chronic obstructive pulmonary disease (COPD), and several novel therapies aim at the suppression of neutrophils…”
Get more information